125 related articles for article (PubMed ID: 18598197)
1. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.
Ulenga NK; Sarr AD; Thakore-Meloni S; Sankalé JL; Eisen G; Kanki PJ
J Infect Dis; 2008 Aug; 198(4):486-92. PubMed ID: 18598197
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO
J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564
[TBL] [Abstract][Full Text] [Related]
3. Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Henriet S; Mercenne G; Bernacchi S; Paillart JC; Marquet R
Microbiol Mol Biol Rev; 2009 Jun; 73(2):211-32. PubMed ID: 19487726
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G levels predict rates of progression to AIDS.
Jin X; Wu H; Smith H
Retrovirology; 2007 Mar; 4():20. PubMed ID: 17374143
[TBL] [Abstract][Full Text] [Related]
5. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
6. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN; Holmes RK; Malim MH
J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.
Jin X; Brooks A; Chen H; Bennett R; Reichman R; Smith H
J Virol; 2005 Sep; 79(17):11513-6. PubMed ID: 16103203
[TBL] [Abstract][Full Text] [Related]
8. Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.
Wang X; Li X; Ma J; Zhang L; Ma L; Mi Z; Zhou J; Guo F; Kleiman L; Cen S
Virus Res; 2014 Oct; 191():30-8. PubMed ID: 25038404
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome.
Ebrahimi D; Anwar F; Davenport MP
Retrovirology; 2012 Dec; 9():113. PubMed ID: 23256516
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.
Yang Y; Guo F; Cen S; Kleiman L
Virology; 2007 Aug; 365(1):92-100. PubMed ID: 17459442
[TBL] [Abstract][Full Text] [Related]
11. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.
Smith JL; Pathak VK
J Virol; 2010 Dec; 84(24):12599-608. PubMed ID: 20943965
[TBL] [Abstract][Full Text] [Related]
12. Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.
Kobayashi T; Koizumi Y; Takeuchi JS; Misawa N; Kimura Y; Morita S; Aihara K; Koyanagi Y; Iwami S; Sato K
J Virol; 2014 May; 88(10):5881-7. PubMed ID: 24623435
[TBL] [Abstract][Full Text] [Related]
13. The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.
Guo F; Cen S; Niu M; Yang Y; Gorelick RJ; Kleiman L
J Virol; 2007 Oct; 81(20):11322-31. PubMed ID: 17670826
[TBL] [Abstract][Full Text] [Related]
14. High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.
Bertine M; Charpentier C; Visseaux B; Storto A; Collin G; Larrouy L; Damond F; Matheron S; Brun-Vézinet F; Descamps D;
AIDS; 2015 Apr; 29(7):779-84. PubMed ID: 25985400
[TBL] [Abstract][Full Text] [Related]
15. Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
Armitage AE; Katzourakis A; de Oliveira T; Welch JJ; Belshaw R; Bishop KN; Kramer B; McMichael AJ; Rambaut A; Iversen AK
J Virol; 2008 Sep; 82(17):8743-61. PubMed ID: 18562517
[TBL] [Abstract][Full Text] [Related]
16. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.
Pillai SK; Abdel-Mohsen M; Guatelli J; Skasko M; Monto A; Fujimoto K; Yukl S; Greene WC; Kovari H; Rauch A; Fellay J; Battegay M; Hirschel B; Witteck A; Bernasconi E; Ledergerber B; Günthard HF; Wong JK;
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3035-40. PubMed ID: 22315404
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.
Armitage AE; Deforche K; Chang CH; Wee E; Kramer B; Welch JJ; Gerstoft J; Fugger L; McMichael A; Rambaut A; Iversen AK
PLoS Genet; 2012; 8(3):e1002550. PubMed ID: 22457633
[TBL] [Abstract][Full Text] [Related]
18. [Study on the difference of the APOBEC3G mRNA levels among HIV long-term nonprogressors, slow progressors, people at high risks and normal people].
Liu YJ; Li L; Bao ZY; Liu SY; Zhuang DM; Li HP; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):356-9. PubMed ID: 18843993
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.
Bennett RP; Presnyak V; Wedekind JE; Smith HC
J Biol Chem; 2008 Mar; 283(12):7320-7. PubMed ID: 18165230
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
Reddy K; Winkler CA; Werner L; Mlisana K; Abdool Karim SS; Ndung'u T;
AIDS; 2010 Jan; 24(2):195-204. PubMed ID: 19996938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]